Global and United States Pre-Filled Syringes Market Report & Forecast 2022-2028

Market Analysis and Insights: Global and United States Pre-Filled Syringes Market
This report focuses on global and United States Pre-Filled Syringes market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Pre-Filled Syringes market size is estimated to be worth US$ 4607.2 million in 2022 and is forecast to a readjusted size of US$ 5358.6 million by 2028 with a CAGR of 2.6% during the review period. Fully considering the economic change by this health crisis, by Type, Glass Pre-Filled Syringes accounting for % of the Pre-Filled Syringes global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Vaccines was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
In United States the Pre-Filled Syringes market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period.
Global Pre-Filled Syringes Scope and Market Size
Pre-Filled Syringes market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Pre-Filled Syringes market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Pre-Filled Syringes market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Glass Pre-Filled Syringes
Plastic Pre-Filled Syringes
Segment by Application
Vaccines
Monoclonal Antibodies
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
BD
Gerresheimer
Schott
Baxter
Nipro
Ompi（Stevanato Group）
Weigao
Unilife
Roselabs
Vetter Pharma
National Medical Products
Robert Bosch GmbH
Owen Mumford
Ypsomed
SHL Group
Bespak
ROVI CM
Terumo
Taisei Kako Co.
ARTE CORPORATION